Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -12.58%80.39M | -47.11%13.99M | -43.27%15.7M | 35.53%37.84M | 29.73%12.86M | 133.06%91.96M | -23.21%26.45M | 135.38%27.67M | 46.06%27.92M | 138.33%9.91M |
Net income from continuing operations | -43.44%24.13M | -52.85%7.82M | 97.28%-267K | -37.63%11.8M | -71.89%4.77M | -70.17%42.66M | -85.98%16.58M | -177.03%-9.83M | 159.13%18.92M | 265.30%16.98M |
Depreciation and amortization | 19.92%12.63M | 18.28%3.29M | 18.82%3.15M | 22.98%3.18M | 19.74%3M | 0.19%10.53M | 11.04%2.79M | 2.04%2.65M | -4.54%2.59M | -6.94%2.51M |
Deferred tax | 23.83%14.04M | -34.10%5.85M | 125.63%1.67M | -32.42%4.02M | -16.81%2.5M | 34.83%11.33M | 185.74%8.88M | -364.97%-6.5M | 316.95%5.95M | 111.35%3M |
Other non cash items | 42.86%3.09M | -86.23%156K | -54.12%156K | -54.68%155K | 650.29%2.63M | 102.11%2.17M | 101.09%1.13M | 0.29%340K | -16.18%342K | 26.81%350K |
Change In working capital | 90.75%-5.6M | -2.08%-8.13M | 65.58%-5.14M | 191.58%13.3M | 75.63%-5.63M | -56.83%-60.49M | -202.43%-7.97M | -43.71%-14.92M | -625.93%-14.52M | 40.41%-23.08M |
-Change in receivables | 160.10%48.24M | 202.19%10.08M | 100.98%183K | 174.06%17.53M | 172.77%20.45M | -258.52%-80.26M | -162.72%-9.86M | -72.39%-18.63M | -3,491.83%-23.68M | -0.33%-28.1M |
-Change in inventory | -138.93%-5.84M | 28.97%8.71M | -200.51%-6.89M | -119.72%-907K | -111.48%-6.76M | 140.65%15.01M | 1.21%6.76M | 142.30%6.85M | 128.23%4.6M | 71.23%-3.2M |
-Change in payables and accrued expense | -158.19%-5.61M | -294.34%-4.25M | 191.17%10.52M | 104.29%187K | -205.29%-12.07M | 1,149.18%9.64M | 88.98%-1.08M | 3,828.26%3.61M | -144.67%-4.36M | 1,267.41%11.46M |
-Change in other current assets | -820.81%-9.77M | -378.72%-7.1M | -315.25%-1.88M | 95.07%2.37M | 3.54%-3.17M | 455.33%1.36M | 307.52%2.55M | -48.03%872K | -10.65%1.22M | 4.09%-3.28M |
-Change in other working capital | -423.25%-32.61M | -146.03%-15.57M | 7.23%-7.08M | -176.51%-5.89M | -13,241.94%-4.07M | -129.10%-6.23M | -15.91%-6.33M | -151.38%-7.63M | 6.31%7.7M | -99.35%31K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -12.58%80.39M | -47.11%13.99M | -43.27%15.7M | 35.53%37.84M | 29.73%12.86M | 133.06%91.96M | -23.21%26.45M | 135.38%27.67M | 46.06%27.92M | 138.33%9.91M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 22.62%-8.39M | 47.85%-1.53M | 32.74%-2.38M | 15.67%-2M | -23.96%-2.48M | -196.61%-10.85M | -285.81%-2.94M | -373.09%-3.53M | -87.37%-2.37M | -127.10%-2M |
Net PPE purchase and sale | 20.66%-8.39M | 47.85%-1.53M | 27.20%-2.38M | 15.67%-2M | -23.96%-2.48M | -235.38%-10.58M | -285.81%-2.94M | -1,238.11%-3.27M | -87.37%-2.37M | -127.10%-2M |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | 46.52%-269K | --0 | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 22.62%-8.39M | 47.85%-1.53M | 32.74%-2.38M | 15.67%-2M | -23.96%-2.48M | -196.61%-10.85M | -285.81%-2.94M | -373.09%-3.53M | -87.37%-2.37M | -127.10%-2M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -5.99%-71.19M | 99.48%-52K | 73.98%-5.41M | -83.14%-47.89M | -74.71%-17.85M | -83.57%-67.17M | 82.26%-10.03M | -550.06%-20.78M | -266.82%-26.15M | -133.76%-10.22M |
Net issuance payments of debt | 29.41%-42M | --0 | 75.61%-5M | 13.73%-22M | -328.57%-15M | -550.98%-59.5M | 73.78%-10M | ---20.5M | -363.64%-25.5M | -110.14%-3.5M |
Net common stock issuance | ---25.33M | --0 | ---100K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other financing activities | 49.65%-3.86M | -85.71%-52K | -10.51%-305K | -1.24%-655K | 57.59%-2.85M | 89.11%-7.67M | 99.95%-28K | 91.36%-276K | 60.26%-647K | -58.58%-6.72M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -5.99%-71.19M | 99.48%-52K | 73.98%-5.41M | -83.14%-47.89M | -74.71%-17.85M | -83.57%-67.17M | 82.26%-10.03M | -550.06%-20.78M | -266.82%-26.15M | -133.76%-10.22M |
Net cash flow | ||||||||||
Beginning cash position | 159.03%22.71M | 20.40%11.11M | -45.58%3.19M | 135.85%15.24M | 159.03%22.71M | -8.28%8.77M | -70.82%9.22M | -75.38%5.86M | -50.62%6.46M | -8.28%8.77M |
Current changes in cash | -94.23%804K | -8.00%12.41M | 135.34%7.92M | -1,907.83%-12.05M | -223.98%-7.47M | 1,862.45%13.94M | 159.01%13.48M | -56.95%3.36M | -105.60%-600K | -165.44%-2.31M |
End cash Position | 3.54%23.51M | 3.54%23.51M | 20.40%11.11M | -45.58%3.19M | 135.85%15.24M | 159.03%22.71M | 159.03%22.71M | -70.82%9.22M | -75.38%5.86M | -50.62%6.46M |
Free cash flow | -11.53%72M | -47.02%12.46M | -45.42%13.32M | 40.29%35.84M | 31.19%10.38M | 124.17%81.38M | -30.19%23.51M | 112.01%24.41M | 43.13%25.55M | 129.58%7.91M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |